DISCLAIMERThe information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
|You are receiving this because you have an account on www.oneGRAVESvoice.com|
|To unsubscribe from these emails, click here|
Trusted Resources: News & Meetings
Latest announcements and gatherings
Researchers at the National Institutes of Health have identified a compound that prevents overproduction of thyroid hormone, a finding that brings scientists one step closer to improving treatment for Graves’ disease.
In Graves’ disease, the thyroid gland never stops. Thyroid-stimulating antibodies bind to receptors, activating them to keep the thyroid hormone coming and coming — like a broken traffic light stuck on green — and causing the body problems in regulating energy, controlling other hormones and maintaining cells throughout the body.
Attacking the problem at its root cause, lead researcher Susanne Neumann, PhD, and her colleagues at the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) have identified a chemical compound that binds to the receptors and acts as an antagonist, keeping the stimulating antibodies from their work and potentially allowing the thyroid cells to revert to normal function.
Evidence & EducationSubclinical Hypothyroidism After 131I-Treatment of Graves’ Disease: A Risk Factor for Depression?Objectives: Although it is well accepte...
Evidence & EducationPathogenesis of Thyroid Eye Disease: Review and Update on Molecular MechanismsOrbital changes in thyroid orbitopathy (...
Evidence & EducationConversion to Graves’ Disease from Hashimoto Thyroiditis: A Study of 24 patientsObjective: The conversion of Hashimoto'...
Evidence & EducationThe Long-Term Outcomes of Thyroid Function After Subtotal Thyroidectomy for Graves’ HyperthyroidismBackground: Surgical management of Grav...
Evidence & EducationRadioiodine Therapy for HyperthyroidismA 37-year-old woman receives a diagnosis...
Community CenterNatasha’s Story – HyperthyroidismNatasha completed the London Marathon in...
Evidence & EducationDouble-Blind, Placebo-Controlled, Randomized Trial of Selenium in Graves HyperthyroidismContext: Supplemental selenium (Se) may...
send a message
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.